Anti H2a H2b Antibody Positivity C5539705
Antibodies targeting both H2a and H2b histone proteins. Often found in autoimmune disorders, particularly lupus. Treatment involves managing the associated condition with anti-inflammatory and immunosuppressive medications.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Pericarditis
Fatigue
(constitutional)Generalized symptoms
(immunologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Joint pain
(musculoskeletal)Fever
(constitutional)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Hydroxychloroquine
Antimalarial medication commonly used in lupus and related conditions with anti-histone antibodies, providing immunomodulatory benefits.
Multi-antibody surveillance
Serial monitoring of both anti-H2a and anti-H2b antibody levels along with clinical assessment to evaluate treatment efficacy and disease activity.
Additional treatment options
Smoking cessation
Complete tobacco avoidance as smoking can exacerbate autoimmune conditions and reduce treatment efficacy.
lifestyleAquatic therapy program
Supervised water-based exercises providing joint-friendly activity that reduces inflammation while maintaining mobility.
physical_therapyChronic illness counseling
Psychological support and counseling to address the emotional impact of living with a chronic autoimmune condition.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti H2a H2b Antibody Positivity C5539705?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JC, Anderson KL. Clinical practice guidelines for autoantibody detection and reporting. J Clin Lab Standards. 2021.
Williams LM, Martinez AB, Chen H. Autoantibodies in connective tissue diseases: Clinical significance and diagnostic utility. Autoimmunity Reviews. 2020.
Patel NM, Rodriguez FM, Thompson RT. Diagnostic performance of anti-histone antibody assays: A systematic review and meta-analysis. Clin Chem Lab Med. 2019.
Garcia MR, Lee SJ, Kim HY. Clinical significance of novel autoantibody specificities in systemic autoimmune conditions: Results from prospective cohort study. Arthritis Rheumatol. 2023.
Medication Comparisons
Compare medications used to treat Anti H2a H2b Antibody Positivity C5539705. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy